Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
about
The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.Serotonergic modulation of conditioned fear.Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial.Panic attacks 10 years after heart transplantation successfully treated with low-dose citalopram: a case reportNew treatment options for panic disorder: clinical trials from 2000 to 2010.
P2860
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@en
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@nl
type
label
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@en
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@nl
prefLabel
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@en
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@nl
P2860
P356
P1476
Selective serotonin-reuptake i ...... of placebo-controlled studies.
@en
P2093
Antonio Egidio Nardi
Marina Dyskant Mochcovitch
P2860
P304
P356
10.1586/ERN.10.110
P577
2010-08-01T00:00:00Z